Lazard (LAZ) Competitors $51.80 +0.53 (+1.02%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$51.79 -0.02 (-0.03%) As of 08/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LAZ vs. AMP, EQH, EVR, GS, JEF, JHG, MC, MS, PIPR, and SFShould you be buying Lazard stock or one of its competitors? The main competitors of Lazard include Ameriprise Financial (AMP), Equitable (EQH), Evercore (EVR), The Goldman Sachs Group (GS), Jefferies Financial Group (JEF), Janus Henderson Group (JHG), Moelis & Company (MC), Morgan Stanley (MS), Piper Sandler Companies (PIPR), and Stifel Financial (SF). These companies are all part of the "finance" sector. Lazard vs. Its Competitors Ameriprise Financial Equitable Evercore The Goldman Sachs Group Jefferies Financial Group Janus Henderson Group Moelis & Company Morgan Stanley Piper Sandler Companies Stifel Financial Lazard (NYSE:LAZ) and Ameriprise Financial (NYSE:AMP) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Does the media refer more to LAZ or AMP? In the previous week, Ameriprise Financial had 1 more articles in the media than Lazard. MarketBeat recorded 22 mentions for Ameriprise Financial and 21 mentions for Lazard. Ameriprise Financial's average media sentiment score of 1.63 beat Lazard's score of 0.19 indicating that Ameriprise Financial is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lazard 4 Very Positive mention(s) 1 Positive mention(s) 11 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral Ameriprise Financial 20 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has preferable earnings and valuation, LAZ or AMP? Ameriprise Financial has higher revenue and earnings than Lazard. Ameriprise Financial is trading at a lower price-to-earnings ratio than Lazard, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLazard$3.05B1.91$279.91M$2.9017.86Ameriprise Financial$17.26B2.75$3.40B$32.1415.70 Which has more volatility & risk, LAZ or AMP? Lazard has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, Ameriprise Financial has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Do insiders and institutionals have more ownership in LAZ or AMP? 54.8% of Lazard shares are held by institutional investors. Comparatively, 84.0% of Ameriprise Financial shares are held by institutional investors. 3.9% of Lazard shares are held by company insiders. Comparatively, 0.7% of Ameriprise Financial shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is LAZ or AMP more profitable? Ameriprise Financial has a net margin of 18.30% compared to Lazard's net margin of 9.96%. Ameriprise Financial's return on equity of 65.90% beat Lazard's return on equity.Company Net Margins Return on Equity Return on Assets Lazard9.96% 34.33% 5.24% Ameriprise Financial 18.30%65.90%2.02% Do analysts rate LAZ or AMP? Lazard currently has a consensus price target of $51.50, indicating a potential downside of 0.59%. Ameriprise Financial has a consensus price target of $534.71, indicating a potential upside of 5.99%. Given Ameriprise Financial's stronger consensus rating and higher possible upside, analysts clearly believe Ameriprise Financial is more favorable than Lazard.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lazard 2 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00Ameriprise Financial 2 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.13 Is LAZ or AMP a better dividend stock? Lazard pays an annual dividend of $2.00 per share and has a dividend yield of 3.9%. Ameriprise Financial pays an annual dividend of $6.40 per share and has a dividend yield of 1.3%. Lazard pays out 69.0% of its earnings in the form of a dividend. Ameriprise Financial pays out 19.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ameriprise Financial has raised its dividend for 21 consecutive years. SummaryAmeriprise Financial beats Lazard on 14 of the 20 factors compared between the two stocks. Get Lazard News Delivered to You Automatically Sign up to receive the latest news and ratings for LAZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LAZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LAZ vs. The Competition Export to ExcelMetricLazardFIN IndustryFinance SectorNYSE ExchangeMarket Cap$5.78B$7.51B$12.21B$20.69BDividend Yield3.90%4.89%5.65%3.66%P/E Ratio17.8618.6119.6328.44Price / Sales1.916.3126.2756.02Price / Cash7.9320.6221.2823.21Price / Book7.432.602.114.33Net Income$279.91M$310.82M$1.00B$996.14M7 Day Performance3.34%2.70%1.27%1.98%1 Month Performance1.70%7.00%-0.02%-0.84%1 Year Performance14.11%34.51%540.35%14.36% Lazard Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LAZLazard4.1446 of 5 stars$51.81+1.0%$51.50-0.6%+16.3%$5.78B$3.05B17.863,263Trending NewsAMPAmeriprise Financial4.5557 of 5 stars$518.10-0.6%$533.86+3.0%+26.0%$49.33B$17.26B16.1213,600EQHEquitable4.5387 of 5 stars$52.30-0.6%$65.30+24.9%+37.0%$15.78B$14.78B14.218,000Positive NewsEx-DividendAnalyst ForecastEVREvercore4.6081 of 5 stars$302.33+0.4%$283.14-6.3%+27.0%$11.83B$3.09B28.932,380Analyst UpgradeInsider TradeGSThe Goldman Sachs Group4.5986 of 5 stars$723.85-0.7%$660.00-8.8%+48.6%$222.11B$126.85B15.9546,500Trending NewsJEFJefferies Financial Group4.3645 of 5 stars$57.54-0.2%$66.00+14.7%+5.7%$11.87B$7.03B21.717,822JHGJanus Henderson Group4.5851 of 5 stars$42.96-0.4%$43.33+0.9%+24.5%$6.77B$2.54B17.052,300Positive NewsDividend AnnouncementInsider TradeMCMoelis & Company2.2263 of 5 stars$71.27+1.2%$66.00-7.4%+15.6%$5.60B$1.19B28.061,309Positive NewsMSMorgan Stanley4.6236 of 5 stars$142.46-0.4%$138.25-3.0%+51.4%$228.55B$107.29B16.1380,000Trending NewsAnalyst RevisionPIPRPiper Sandler CompaniesN/A$314.03-0.1%$312.50-0.5%N/A$5.58B$1.49B27.451,805News CoveragePositive NewsEarnings ReportDividend IncreaseAnalyst UpgradeInsider TradeSFStifel Financial4.2119 of 5 stars$111.78-0.8%$110.88-0.8%+37.6%$11.48B$4.97B21.379,000Dividend Announcement Related Companies and Tools Related Companies AMP Competitors EQH Competitors EVR Competitors GS Competitors JEF Competitors JHG Competitors MC Competitors MS Competitors PIPR Competitors SF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:LAZ) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lazard, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lazard With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.